المؤلفون: Ludwig, Heinz, Terpos, Evangelos, van de Donk, Niels, Mateos, Maria-Victoria, Moreau, Philippe, Dimopoulos, Melitios-Athanasios, Delforge, Michel, Rodriguez-Otero, Paula, San-Miguel, Jesús, Yong, Kwee, Gay, Francesca, Einsele, Hermann, Mina, Roberto, Caers, Jo, Driessen, Christoph, Musto, Pellegrino, Zweegman, Sonja, Engelhardt, Monika, Cook, Gordon, Weisel, Katja, Broijl, Annemiek, Beksac, Meral, Bila, Jelena, Schjesvold, Fredrik, Cavo, Michele, Hajek, Roman, Touzeau, Cyrille, Boccadoro, Mario, Sonneveld, Pieter

المصدر: The Lancet Oncology, 24 (6), e255 - e269 (2023-06)

مصطلحات موضوعية: cell-associated neurotoxicity, Antibodies, Bispecific, Interleukin 1 Receptor Antagonist Protein, Humans, Cytokine Release Syndrome/etiology, Cytokine Release Syndrome/prevention & control, Cytokine Release Syndrome/drug therapy, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Consensus, Immunotherapy, Adoptive/adverse effects, T-Lymphocytes, Multiple Myeloma/drug therapy, Antibodies, Bispecific/adverse effects, Cytokine Release Syndrome, Immunotherapy, Adoptive, Multiple Myeloma, Oncology, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

Relation: https://api.elsevier.com/content/article/PII:S1470204523001596?httpAccept=text/xml; urn:issn:1470-2045; urn:issn:1474-5488

URL الوصول: https://orbi.uliege.be/handle/2268/310482